Reverzna transkriptaza telomeraze

TERT
Available structures
PDBPretraga ortologa: PDBe RCSB
Identifikatori
AlijasiTERT
Spoljašnji IDOMIM: 187270 MGI: 1202709 HomoloGene: 31141 GeneCards: TERT
Obrazac RNK izražavanja
More reference expression data
Ortolozi
VrsteČovekMiš
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001193376
NM_198253
NM_198254
NM_198255

NM_009354
NM_001362387
NM_001362388

RefSeq (protein)

NP_001180305
NP_937983

NP_033380
NP_001349316
NP_001349317

Location (UCSC)n/aChr 13: 73.78 – 73.8 Mb
PubMed search[2][3]
Wikidata
View/Edit HumanView/Edit Mouse

Reverzna transkriptaza telomeraze (TERT, ili hTERT kod ljudi) je katalitička podjedinica enzima telomeraza, koja, zajedno sa telomeraznom RNK komponentom (TERC), sačinjava najvažniju jedinicu telomeraznog kompleksa.[4][5]

Telomeraze su deo distinktne podgrupe RNK-zavisnih polimeraza. Telomeraze produžavaju telomere u DNK lancima, čime omogućavaju starećim ćelijama koje bi postale postmitotičke i podlegle apoptozi da premaše Hejflikov limit i postanu potencijalno besmrtne, kao što je to često slučaj sa ćelijama raka. Specifično, TERT je odgovoran za katalizu adicije nukleotida u TTAGGG sequenci na krajevima hromozomskih telomera.[6] Ova adicija ponavljajućih DNK sekvenci spečava degradaciju krajeva hromozoma nakon višestrukih ciklusa replikacije.[7]

hTERT odstustvo (obično usled hromozomske mutacije) je vezano za sindrom mačjeg plača.[8][9]

Reverzna transkriptaza telomeraze formira interakcije sa:

  1. ^ а б в GRCm38: Ensembl release 89: ENSMUSG00000021611 - Ensembl, May 2017
  2. ^ „Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine. 
  3. ^ „Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine. 
  4. ^ Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB (1997). „Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT”. Nat. Genet. 17 (4): 498—502. PMID 9398860. doi:10.1038/ng1297-498. 
  5. ^ Kirkpatrick KL, Mokbel K (2001). „The significance of human telomerase reverse transcriptase (hTERT) in cancer”. Eur J Surg Oncol. 27 (8): 754—60. PMID 11735173. doi:10.1053/ejso.2001.1151. 
  6. ^ Shampay J, Blackburn EH (1988). „Generation of telomere-length heterogeneity in Saccharomyces cerevisiae”. Proc. Natl. Acad. Sci. U.S.A. 85 (2): 534—8. PMC 279585Слободан приступ. PMID 3277178. doi:10.1073/pnas.85.2.534. 
  7. ^ Poole JC, Andrews LG, Tollefsbol TO (2001). „Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)”. Gene. 269 (1-2): 1—12. PMID 11376932. doi:10.1016/S0378-1119(01)00440-1. 
  8. ^ Zhang A, Zheng C, Hou M, Lindvall C, Li KJ, Erlandsson F, Björkholm M, Gruber A, Blennow E, Xu D (2003). „Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome”. Am. J. Hum. Genet. 72 (4): 940—8. PMC 1180356Слободан приступ. PMID 12629597. doi:10.1086/374565. 
  9. ^ Cerruti Mainardi P (2006). „Cri du Chat syndrome”. Orphanet J Rare Dis. 1: 33. PMC 1574300Слободан приступ. PMID 16953888. doi:10.1186/1750-1172-1-33. 
  10. ^ Haendeler J, Hoffmann J, Rahman S, Zeiher AM, Dimmeler S (2003). „Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation”. FEBS Lett. 536 (1-3): 180—6. PMID 12586360. doi:10.1016/S0014-5793(03)00058-9. 
  11. ^ Kawauchi K, Ihjima K, Yamada O (2005). „IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells”. J. Immunol. 174 (9): 5261—9. PMID 15843522. doi:10.4049/jimmunol.174.9.5261. 
  12. ^ а б Chai W, Ford LP, Lenertz L, Wright WE, Shay JW (2002). „Human Ku70/80 associates physically with telomerase through interaction with hTERT”. J. Biol. Chem. 277 (49): 47242—7. PMID 12377759. doi:10.1074/jbc.M208542200. 
  13. ^ Song H, Li Y, Chen G, Xing Z, Zhao J, Yokoyama KK, Li T, Zhao M (2004). „Human MCRS2, a cell-cycle-dependent protein, associates with LPTS/PinX1 and reduces the telomere length”. Biochem. Biophys. Res. Commun. 316 (4): 1116—23. PMID 15044100. doi:10.1016/j.bbrc.2004.02.166. 
  14. ^ Khurts S, Masutomi K, Delgermaa L, Arai K, Oishi N, Mizuno H, Hayashi N, Hahn WC, Murakami S (2004). „Nucleolin interacts with telomerase”. J. Biol. Chem. 279 (49): 51508—15. PMID 15371412. doi:10.1074/jbc.M407643200. 
  15. ^ Zhou XZ, Lu KP (2001). „The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor”. Cell. 107 (3): 347—59. PMID 11701125. doi:10.1016/S0092-8674(01)00538-4. 
  16. ^ Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T (2000). „Involvement of 14-3-3 proteins in nuclear localization of telomerase”. EMBO J. 19 (11): 2652—61. PMC 212742Слободан приступ. PMID 10835362. doi:10.1093/emboj/19.11.2652. 
  • Mattson MP, Fu W, Zhang P (2001). „Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective”. Mech. Ageing Dev. 122 (7): 659—71. PMID 11322991. doi:10.1016/S0047-6374(01)00221-4. 
  • Castillo Ureta H, Barrera Saldaña HA, Martínez Rodríguez HG (2003). „[Telomerase: an enzyme with multiple applications in cancer research]”. Rev. Invest. Clin. 54 (4): 342—8. PMID 12415959. 
  • Janknecht R (2004). „On the road to immortality: hTERT upregulation in cancer cells”. FEBS Lett. 564 (1–2): 9—13. PMID 15094035. doi:10.1016/S0014-5793(04)00356-4. 
  • Cristofari G, Sikora K, Lingner J (2007). „Telomerase unplugged”. ACS Chem. Biol. 2 (3): 155—8. PMID 17373762. doi:10.1021/cb700037c. 
  • Beliveau A, Yaswen P (2007). „Soothing the watchman: telomerase reduces the p53-dependent cellular stress response”. Cell Cycle. 6 (11): 1284—7. PMID 17534147. doi:10.4161/cc.6.11.4298. 
  • Bellon M, Nicot C (2007). „Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia”. Cancer genomics & proteomics. 4 (1): 21—5. PMID 17726237. 

Spoljašnje veze

[уреди | уреди извор]